Skip to main content

Table 1 Demographics and baseline characteristics of patients with SARS-CoV-2 pneumonia

From: Clinical features and predictors for patients with severe SARS-CoV-2 pneumonia at the start of the pandemic: a retrospective multicenter cohort study

Age, years All patients (n = 58) Non-severe (n = 35) Severe (n = 23)
47·8 (13·8) 46·0 (12·7) 50·5 (15·2)
Age range, years
 20–29 7 (12·1%) 5 (14·3%) 2 (8·7%)
 30–39 13 (22·4%) 8 (22·9%) 5 (21·7%)
 40–49 9 (15·5%) 6 (17·1%) 3 (13·0%)
 50–59 19 (32·8%) 11 (31·4%) 8 (34·8%)
 60–69 7 (12·1%) 5 (14·3%) 2 (8·7%)
 70–79 2 (3·5%) 0 2 (8·7%)
  ≥ 80 1 (1·7%) 0 1 (4·4%)
Gender
 Female 28 (48·3%) 22 (62·9%) 6 (26·1%)
 Male 30 (51·7%) 13 (37·1%) 17 (73·9%)
Comorbidities
 None 43 (74·1%) 28 (80·0%) 15 (65·2%)
 Hypertension 9 (15·5%) 4 (11·4%) 5 (21·7%)
 Diabetes 1 (1·7%) 0 1 (4·4%)
 Chronic kidney disease 1 (1·7%) 0 1 (4·4%)
 Malignancy 1 (1·7%) 0 1 (4·4%)
 Others 5 (8·6%) 3 (8·6%) 2 (8·7%)
Symptoms
 Fever 24 (41·4%) 12 (34·3%) 12 (52·2%)
 Cough 34 (58·6%) 22 (62·9%) 12 (52·2%)
 Sore throat 6 (10·3%) 2 (5·7%) 4 (17·4%)
 Nausea 6 (10·3%) 5 (14·3%) 1 (4·4%)
 Anorexic 5 (8·6%) 4 (11·4%) 1 (4·4%)
 Diarrhea 4 (6·9%) 3 (8·6%) 1 (4·4%)
 Muscle soreness 10 (17·2%) 6 (17·1%) 4 (17·4%)
 Dyspnea 9 (15·5%) 4 (18·2%) 5 (23·8%)
 Fatigue 18 (31·0%) 10 (28·6%) 8 (34·8%)
Severity of cough
 Absent 24 (41·4%) 13 (37·1%) 11 (47·8%)
 Mild 10 (17·2%) 9 (25·7%) 1 (4·4%)
 Moderate 18 (31·0%) 10 (28·6%) 8 (34·8%)
 Severe 6 (10·3%) 3 (8·6%) 3 (13·0%)
  1. Footnote: Data are n (%), mean (SD) or median (IQR), unless otherwise stated